An early pilot study has shown that special analysis of the lens of the eye by a newly developed biomicroscope could be able to predict Type 2 diabetes.
In a new study, researchers from Osaka University (Japan) have demonstrated that measuring methylation of microRNA could accurately distinguish individuals with early pancreatic cancer from healthy controls.
A novel microarray has been developed by researchers that incorporates both physical and electrostatic features to improve diagnostic methods for cervical cancer.
In this interview, Stephanie Traub (Cancer Research UK; London, UK) discusses her work as a biomarker specialist and the challenges she faces when developing biomarker strategies.
In these three posters, Charles Rivers (MA, USA) discuss the challenges associated with flow cytometry validation, compare data generated against that by microscopy, and compile historical immunophenotyping data in preclinical species.
In this interview, David Harris (Charles River Laboratories; NC, USA) discusses the current global landscape for cell therapy, associated safety concerns and challenges, and preclinical animal models that are used to evaluate cellular therapies.
Find out more about the CAR-T cell therapy workflow in this informative infographic from Bio-Rad…
In these two case studies, Eurofins (MO, USA) shares details of how they have used flow cytometry as a bioanalytical tool in clinical sample receptor occupancy assays and regulated environments.
In this methodology from Bioanalysis, the authors investigate the detection of Ki67 – a prognostic and/or predictive biomarker in patients with malignancies – in human blood using flow cytometry for single-cell multiparameter analysis.
In this article, details of the tailored solutions KCAS (KS, USA) offers for flow cytometry are discussed including 13 prequalified biomarker immune monitoring panels for support of clinical trials.